Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
5
×
life sciences
national blog main
national top stories
biotech
boston blog main
boston top stories
san francisco blog main
san francisco top stories
startups
crispr
national
pfizer
roche
alzheimer's disease
amgen
biogen
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
crispr therapeutics
cystic fibrosis
detroit blog main
detroit top stories
diagnostics
europe blog main
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
investing
jennifer doudna
mammoth biosciences
merck
messenger rna
new york blog main
new york top stories
What
crispr
5
×
bio
gene
roundup
today
access
acquisitions
advanced
albert
alliance
available
based
big
biggest
biosciences
bourla
bristol
buy
calls
capacity
car
cas
cell
ceo
changing
cheaper
color
company
consolidation
create
days
develop
diagnostic
diagnostics
diseases
drug
editing
expects
falcon
faster
Language
unset
unknown
Current search:
crispr
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M